Literature DB >> 9781018

Modifier genes in humans: strategies for identification.

R S Houlston1, I P Tomlinson.   

Abstract

A number of genetic disorders exhibit inter- and intra-familial variability. Understanding the factors that control the expression of disease genes should provide insight into the fundamental disease processes and will have implications for counselling patients. Different mechanisms can account for this variability, including environmental factors, genotype-phenotype correlations and imprinting. There is also evidence that, in a number of genetic diseases, gene expression is under the control of modifier loci. In cases where the biological basis of the genetic disease is understood, any genes involved in the pathogenic process represent candidate modifier genes which can easily be evaluated. Alternatively, modifiers can be identified through approaches such as mouse models. Since modifier genes will generally be common and because of confounding environmental influences, linkage analyses in humans will generally be based upon affected or discordant sib pairs. Discordant sib pairs represent an attractive option for linkage studies, because recurrence rates are high and the reduced survival characteristics associated with severe phenotypes will make the likelihood of obtaining clinical material from two living cases difficult. Furthermore, the use of discordant siblings will select for those siblings which possess sufficient dissimilarity at the modifier locus to overcome any shared environmental influence.

Entities:  

Mesh:

Year:  1998        PMID: 9781018     DOI: 10.1038/sj.ejhg.5200156

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  16 in total

1.  Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes.

Authors:  R Houlston; M Crabtree; R Phillips; M Crabtree; I Tomlinson
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

Review 2.  Identifying modifier genes of monogenic disease: strategies and difficulties.

Authors:  Emmanuelle Génin; Josué Feingold; Françoise Clerget-Darpoux
Journal:  Hum Genet       Date:  2008-09-11       Impact factor: 4.132

3.  Identifying modifier loci in existing genome scan data.

Authors:  E W Daw; Y Lu; A J Marian; S Shete
Journal:  Ann Hum Genet       Date:  2008-05-16       Impact factor: 1.670

4.  Variability in the severity of colonic disease in familial adenomatous polyposis results from differences in tumour initiation rather than progression and depends relatively little on patient age.

Authors:  M D Crabtree; I P Tomlinson; I C Talbot; R K Phillips
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

Review 5.  Strain background effects and genetic modifiers of hearing in mice.

Authors:  Kenneth R Johnson; Qing Yin Zheng; Konrad Noben-Trauth
Journal:  Brain Res       Date:  2006-03-31       Impact factor: 3.252

6.  Angiotensinogen gene variations and LV outflow obstruction in hypertrophic cardiomyopathy.

Authors:  S Wang; J Wang; Y Zou; J Wang; H Wang; R Hui
Journal:  Herz       Date:  2013-07-25       Impact factor: 1.443

7.  Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results.

Authors:  Ruslan Dorfman; Weili Li; Lei Sun; Fan Lin; Yongqian Wang; Andrew Sandford; Peter D Paré; Karen McKay; Hana Kayserova; Tereza Piskackova; Milan Macek; Kamila Czerska; Dorota Sands; Harm Tiddens; Sonia Margarit; Gabriela Repetto; Marci K Sontag; Frank J Accurso; Scott Blackman; Garry R Cutting; Lap-Chee Tsui; Mary Corey; Peter Durie; Julian Zielenski; Lisa J Strug
Journal:  Hum Genet       Date:  2009-12       Impact factor: 4.132

8.  Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report.

Authors:  Giovanni Ponti; Annamaria Pollio; Lorenza Pastorino; Giovanni Pellacani; Cristina Magnoni; Sabina Nasti; Giulio Fortuna; Aldo Tomasi; Giovanna Bianchi Scarrà; Stefania Seidenari
Journal:  Oncol Lett       Date:  2012-05-08       Impact factor: 2.967

9.  Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1.

Authors:  Audrey Sabbagh; Eric Pasmant; Ingrid Laurendeau; Béatrice Parfait; Sébastien Barbarot; Bernard Guillot; Patrick Combemale; Salah Ferkal; Michel Vidaud; Patrick Aubourg; Dominique Vidaud; Pierre Wolkenstein
Journal:  Hum Mol Genet       Date:  2009-05-05       Impact factor: 6.150

10.  The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis.

Authors:  Fernando A L Marson; Carmen S Bertuzzo; Taís D R Hortencio; José D Ribeiro; Luciana C Bonadia; Antônio F Ribeiro
Journal:  BMC Pulm Med       Date:  2012-08-08       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.